{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:51:50Z","timestamp":1792036310745,"version":"4.4.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T00:00:00Z","timestamp":1395100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s12035-014-8663-3","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T22:03:38Z","timestamp":1395093818000},"page":"107-118","source":"Crossref","is-referenced-by-count":46,"title":["Mitochondrial Membrane Fluidity is Consistently Increased in Different Models of Huntington Disease: Restorative Effects of Olesoxime"],"prefix":"10.1007","volume":"50","author":[{"given":"Janett","family":"Eckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schamim H.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hagl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Yu-Taeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Bordet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Pruss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Leuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huu P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter P.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"issue":"6","key":"8663_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u2013983","journal-title":"Cell"},{"issue":"10","key":"8663_CR2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/hmg\/2.10.1547","volume":"2","author":"OC Stine","year":"1993","unstructured":"Stine OC, Pleasant N, Franz ML, Abbott MH, Folstein SE, Ross CA (1993) Correlation between the onset age of Huntington\u2019s disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet 2(10):1547\u20131549","journal-title":"Hum Mol Genet"},{"issue":"5","key":"8663_CR3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57(5):369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"8663_CR4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/b95715","volume-title":"Mitochondrial function and biogenetics","author":"LGJ Nijtmans","year":"2004","unstructured":"Nijtmans LGJ, Ugallde C, van den Heuvel LP, Smeitink JAM (2004) Function and dysfunction of the oxidative phospharylation system. In: Koehler C, Bauer MF (eds) Mitochondrial function and biogenetics. Springer Inc., Heidelberg, pp 149\u2013167"},{"issue":"1","key":"8663_CR5","first-page":"147","volume":"8","author":"A Wisniewska","year":"2003","unstructured":"Wisniewska A, Draus J, Subczynski WK (2003) Is a fluid-mosaic model of biological membranes fully relevant? Studies on lipid organization in model and biological membranes. Cell Mol Biol Lett 8(1):147\u2013159","journal-title":"Cell Mol Biol Lett"},{"issue":"1\u20133","key":"8663_CR6","first-page":"519","volume":"100","author":"EJ Helmreich","year":"2003","unstructured":"Helmreich EJ (2003) Environmental influences on signal transduction through membranes: a retrospective mini-review. Biophys Chem 100(1\u20133):519\u2013534","journal-title":"Biophys Chem"},{"issue":"1\u20132","key":"8663_CR7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbamem.2004.08.002","volume":"1666","author":"DA Los","year":"2004","unstructured":"Los DA, Murata N (2004) Membrane fluidity and its roles in the perception of environmental signals. Biochim Biophys Acta 1666(1\u20132):142\u2013157","journal-title":"Biochim Biophys Acta"},{"issue":"7068","key":"8663_CR8","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","volume":"438","author":"FR Maxfield","year":"2005","unstructured":"Maxfield FR, Tabas I (2005) Role of cholesterol and lipid organization in disease. Nature 438(7068):612\u2013621","journal-title":"Nature"},{"issue":"5","key":"8663_CR9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbamem.2009.01.012","volume":"1788","author":"I Peters","year":"2009","unstructured":"Peters I, Igbavboa U, Schutt T, Haidari S, Hartig U, Rosello X, Bottner S, Copanaki E, Deller T, Kogel D, Wood WG, Muller WE, Eckert GP (2009) The interaction of beta-amyloid protein with cellular membranes stimulates its own production. Biochim Biophys Acta 1788(5):964\u2013972","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"8663_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00232-011-9401-7","volume":"244","author":"VA Fajardo","year":"2011","unstructured":"Fajardo VA, McMeekin L, LeBlanc PJ (2011) Influence of phospholipid species on membrane fluidity: a meta-analysis for a novel phospholipid fluidity index. J Membr Biol 244(2):97\u2013103","journal-title":"J Membr Biol"},{"issue":"2","key":"8663_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0005-2736(76)90353-9","volume":"419","author":"J Comte","year":"1976","unstructured":"Comte J, Maisterrena B, Gautheron DC (1976) Lipid composition and protein profiles of outer and inner membranes from pig heart mitochondria. Comparison with microsomes. Biochim Biophys Acta 419(2):271\u2013284","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"8663_CR12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-5793(82)80588-7","volume":"144","author":"C Montecucco","year":"1982","unstructured":"Montecucco C, Smith GA, Dabbeni-sala F, Johannsson A, Galante YM, Bisson R (1982) Bilayer thickness and enzymatic activity in the mitochondrial cytochrome c oxidase and ATPase complex. FEBS Lett 144(1):145\u2013148","journal-title":"FEBS Lett"},{"issue":"8","key":"8663_CR13","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1021\/bi00277a036","volume":"22","author":"TD Madden","year":"1983","unstructured":"Madden TD, Hope MJ, Cullis PR (1983) Lipid requirements for coupled cytochrome oxidase vesicles. Biochemistry 22(8):1970\u20131974","journal-title":"Biochemistry"},{"issue":"29","key":"8663_CR14","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1021\/bi9900828","volume":"38","author":"F Ricchelli","year":"1999","unstructured":"Ricchelli F, Gobbo S, Moreno G, Salet C (1999) Changes of the fluidity of mitochondrial membranes induced by the permeability transition. Biochemistry 38(29):9295\u20139300","journal-title":"Biochemistry"},{"issue":"4","key":"8663_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10863-005-6631-3","volume":"37","author":"AM Aleardi","year":"2005","unstructured":"Aleardi AM, Benard G, Augereau O, Malgat M, Talbot JC, Mazat JP, Letellier T, Dachary-Prigent J, Solaini GC, Rossignol R (2005) Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J Bioenerg Biomembr 37(4):207\u2013225","journal-title":"J Bioenerg Biomembr"},{"issue":"36","key":"8663_CR16","doi-asserted-by":"crossref","first-page":"33928","DOI":"10.1074\/jbc.M210943200","volume":"278","author":"A Colell","year":"2003","unstructured":"Colell A (2003) Cholesterol impairs the adenine nucleotide translocator-mediated mitochondrial permeability transition through altered membrane fluidity. J Biol Chem 278(36):33928\u201333935","journal-title":"J Biol Chem"},{"issue":"21","key":"8663_CR17","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1016\/j.febslet.2007.07.020","volume":"581","author":"T Garofalo","year":"2007","unstructured":"Garofalo T, Tinari A, Matarrese P, Giammarioli AM, Manganelli V, Ciarlo L, Misasi R, Sorice M, Malorni W (2007) Do mitochondria act as \u201ccargo boats\u201d in the journey of GD3 to the nucleus during apoptosis? FEBS Lett 581(21):3899\u20133903","journal-title":"FEBS Lett"},{"issue":"11","key":"8663_CR18","doi-asserted-by":"crossref","first-page":"e81528","DOI":"10.1371\/journal.pone.0081528","volume":"8","author":"C Gouarn\u00e9","year":"2013","unstructured":"Gouarn\u00e9 C, Tardif G, Tracz J, Latyszenok V, Michaud M, Clemens LE, Yu-Taeger L, Nguyen HP, Bordet T, Pruss RM (2013) Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease. PLoS One 8(11):e81528","journal-title":"PLoS One"},{"issue":"3","key":"8663_CR19","doi-asserted-by":"crossref","first-page":"e57932","DOI":"10.1371\/journal.pone.0057932","volume":"8","author":"YN Jin","year":"2013","unstructured":"Jin YN, Yu YV, Gundemir S, Jo C, Cui M, Tieu K, Johnson GV (2013) Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin. PLoS One 8(3):e57932","journal-title":"PLoS One"},{"issue":"7113","key":"8663_CR20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787\u2013795","journal-title":"Nature"},{"key":"8663_CR21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","volume":"1147","author":"SE Browne","year":"2008","unstructured":"Browne SE (2008) Mitochondria and Huntington\u2019s disease pathogenesis: insight from genetic and chemical models. Ann N Y Acad Sci 1147:358\u2013382","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"8663_CR22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","volume":"61","author":"PH Reddy","year":"2009","unstructured":"Reddy PH, Mao P, Manczak M (2009) Mitochondrial structural and functional dynamics in Huntington\u2019s disease. Brain Res Rev 61(1):33\u201348","journal-title":"Brain Res Rev"},{"issue":"3","key":"8663_CR23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10863-010-9287-6","volume":"42","author":"JM Oliveira","year":"2010","unstructured":"Oliveira JM (2010) Mitochondrial bioenergetics and dynamics in Huntington\u2019s disease: tripartite synapses and selective striatal degeneration. J Bioenerg Biomembr 42(3):227\u2013234","journal-title":"J Bioenerg Biomembr"},{"issue":"10","key":"8663_CR24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2174\/1389450111007011218","volume":"11","author":"TR Rosenstock","year":"2010","unstructured":"Rosenstock TR, Duarte AI, Rego AC (2010) Mitochondrial-associated metabolic changes and neurodegeneration in Huntington\u2019s disease\u2014from clinical features to the bench. Curr Drug Targets 11(10):1218\u20131236","journal-title":"Curr Drug Targets"},{"issue":"14","key":"8663_CR25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","volume":"13","author":"YS Choo","year":"2004","unstructured":"Choo YS, Johnson GVW, MacDonald M, Detloff PJ, Lesort M (2004) Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet 13(14):1407\u20131420","journal-title":"Hum Mol Genet"},{"issue":"45","key":"8663_CR26","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.M709555200","volume":"283","author":"FN Gellerich","year":"2008","unstructured":"Gellerich FN, Gizatullina Z, Nguyen HP, Trumbeckaite S, Vielhaber S, Seppet E, Zierz S, Landwehrmeyer B, Riess O, von Horsten S, Striggow F (2008) Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats. J Biol Chem 283(45):30715\u201330724","journal-title":"J Biol Chem"},{"issue":"11","key":"8663_CR27","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, Xu X, Mastroberardino PG, Greenamyre JT, Li XJ (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28(11):2783\u20132792","journal-title":"J Neurosci"},{"issue":"4","key":"8663_CR28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/hmg\/ddn404","volume":"18","author":"H Wang","year":"2009","unstructured":"Wang H, Lim PJ, Karbowski M, Monteiro MJ (2009) Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum Mol Genet 18(4):737\u2013752","journal-title":"Hum Mol Genet"},{"issue":"12","key":"8663_CR29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/emmm.201000102","volume":"2","author":"V Costa","year":"2010","unstructured":"Costa V, Giacomello M, Hudec R, Lopreiato R, Ermak G, Lim D, Malorni W, Davies KJ, Carafoli E, Scorrano L (2010) Mitochondrial fission and cristae disruption increase the response of cell models of Huntington\u2019s disease to apoptotic stimuli. EMBO Mol Med 2(12):490\u2013503","journal-title":"EMBO Mol Med"},{"issue":"20","key":"8663_CR30","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet 19(20):3919\u20133935","journal-title":"Hum Mol Genet"},{"issue":"7","key":"8663_CR31","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, Reddy PH (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet 20(7):1438\u20131455","journal-title":"Hum Mol Genet"},{"issue":"3","key":"8663_CR32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","volume":"17","author":"W Song","year":"2011","unstructured":"Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, Poquiz P, Tjong J, Pouladi MA, Hayden MR, Masliah E, Ellisman M, Rouiller I, Schwarzenbacher R, Bossy B, Perkins G, Bossy-Wetzel E (2011) Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 17(3):377\u2013382","journal-title":"Nat Med"},{"issue":"18","key":"8663_CR33","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","volume":"24","author":"E Trushina","year":"2004","unstructured":"Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V, McPherson PS, Mandavilli BS, Van Houten B, Zeitlin S, McNiven M, Aebersold R, Hayden M, Parisi JE, Seeberg E, Dragatsis I, Doyle K, Bender A, Chacko C, McMurray CT (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24(18):8195\u20138209","journal-title":"Mol Cell Biol"},{"issue":"8","key":"8663_CR34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst C-A, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5(8):731\u2013736","journal-title":"Nat Neurosci"},{"issue":"35","key":"8663_CR35","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","volume":"280","author":"T Milakovic","year":"2005","unstructured":"Milakovic T, Johnson GV (2005) Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. J Biol Chem 280(35):30773\u201330782","journal-title":"J Biol Chem"},{"issue":"3","key":"8663_CR36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/mds.870050317","volume":"5","author":"CG Goety","year":"1990","unstructured":"Goety CG, Tanner CM, Cohen JA, Thelen JA, Carroll VS, Klawans HL, Fariello RG (1990) l-Acetyl-carnitine in Huntington\u2019s disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia. Mov Disord 5(3):263\u2013265","journal-title":"Mov Disord"},{"issue":"5","key":"8663_CR37","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","volume":"22","author":"RJ Ferrante","year":"2002","unstructured":"Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM, Beal MF (2002) Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease. J Neurosci 22(5):1592\u20131599","journal-title":"J Neurosci"},{"issue":"4","key":"8663_CR38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.biopha.2009.06.020","volume":"64","author":"E Vamos","year":"2010","unstructured":"Vamos E, Voros K, Vecsei L, Klivenyi P (2010) Neuroprotective effects of l-carnitine in a transgenic animal model of Huntington\u2019s disease. Biomed Pharmacother 64(4):282\u2013286","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"8663_CR39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mcn.2011.10.007","volume":"49","author":"MA Hickey","year":"2012","unstructured":"Hickey MA, Zhu C, Medvedeva V, Franich NR, Levine MS, Chesselet MF (2012) Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington\u2019s disease. Mol Cell Neurosci 49(2):149\u2013157","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"8663_CR40","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/hmg\/ddr541","volume":"21","author":"A Johri","year":"2012","unstructured":"Johri A, Calingasan NY, Hennessey TM, Sharma A, Yang L, Wille E, Chandra A, Beal MF (2012) Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington\u2019s disease. Hum Mol Genet 21(5):1124\u20131137","journal-title":"Hum Mol Genet"},{"issue":"3","key":"8663_CR41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000334273","volume":"9","author":"R Sandhir","year":"2012","unstructured":"Sandhir R, Sood A, Mehrotra A, Kamboj SS (2012) N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington\u2019s disease. Neurodegener Dis 9(3):145\u2013157","journal-title":"Neurodegener Dis"},{"issue":"2","key":"8663_CR42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.107.123000","volume":"322","author":"T Bordet","year":"2007","unstructured":"Bordet T, Buisson B, Michaud M, Drouot C, Galea P, Delaage P, Akentieva NP, Evers AS, Covey DF, Ostuni MA, Lacapere JJ, Massaad C, Schumacher M, Steidl EM, Maux D, Delaage M, Henderson CE, Pruss RM (2007) Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther 322(2):709\u2013720","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt 1","key":"8663_CR43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/0264-6021:3580147","volume":"358","author":"D Gincel","year":"2001","unstructured":"Gincel D, Zaid H, Shoshan-Barmatz V (2001) Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function. Biochem J 358(Pt 1):147\u2013155","journal-title":"Biochem J"},{"issue":"3","key":"8663_CR44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mam.2010.03.002","volume":"31","author":"V Shoshan-Barmatz","year":"2010","unstructured":"Shoshan-Barmatz V, De Pinto V, Zweckstetter M, Raviv Z, Keinan N, Arbel N (2010) VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol Aspects Med 31(3):227\u2013285","journal-title":"Mol Aspects Med"},{"key":"8663_CR45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1743-7075-7-47","volume":"7","author":"J Hu","year":"2010","unstructured":"Hu J, Zhang Z, Shen WJ, Azhar S (2010) Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr Metab (Lond) 7:47","journal-title":"Nutr Metab (Lond)"},{"issue":"7","key":"8663_CR46","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.neuropharm.2012.02.013","volume":"62","author":"C Sunyach","year":"2012","unstructured":"Sunyach C, Michaud M, Arnoux T, Bernard-Marissal N, Aebischer J, Latyszenok V, Gouarn\u00e9 C, Raoul C, Pruss RM, Bordet T, Pettmann B (2012) Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model. Neuropharmacology 62(7):2346\u20132352","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"8663_CR47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2009.09.006","volume":"147","author":"WH Xiao","year":"2009","unstructured":"Xiao WH, Zheng FY, Bennett GJ, Bordet T, Pruss RM (2009) Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel. Pain 147(1\u20133):202\u2013209","journal-title":"Pain"},{"key":"8663_CR48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neuroscience.2011.12.023","volume":"203","author":"WH Xiao","year":"2012","unstructured":"Xiao WH, Zheng H, Bennett GJ (2012) Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience 203:194\u2013206","journal-title":"Neuroscience"},{"key":"8663_CR49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/ph3020345","volume":"3","author":"T Bordet","year":"2010","unstructured":"Bordet T, Berna P, Abitbol JL, Pruss R (2010) Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound. Pharmaceuticals (Basel) 3:345\u2013368","journal-title":"Pharmaceuticals (Basel)"},{"key":"8663_CR50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biocel.2012.06.009","volume":"45","author":"J Eckmann","year":"2013","unstructured":"Eckmann J, Eckert SH, Leuner K, Muller WE, Eckert GP (2013) Mitochondria: mitochondrial membranes in brain ageing and neurodegeneration. Int J Biochem Cell Biol 45:76\u201380","journal-title":"Int J Biochem Cell Biol"},{"issue":"44","key":"8663_CR51","doi-asserted-by":"crossref","first-page":"15426","DOI":"10.1523\/JNEUROSCI.1148-12.2012","volume":"32","author":"L Yu-Taeger","year":"2012","unstructured":"Yu-Taeger L, Petrasch-Parwez E, Osmand AP, Redensek A, Metzger S, Clemens LE, Park L, Howland D, Calaminus C, Gu X, Pichler B, Yang XW, Riess O, Nguyen HP (2012) A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease. J Neurosci 32(44):15426\u201315438","journal-title":"J Neurosci"},{"issue":"24","key":"8663_CR52","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28(24):6182\u20136195","journal-title":"J Neurosci"},{"issue":"8\u20139","key":"8663_CR53","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s007020170024","volume":"108","author":"GP Eckert","year":"2001","unstructured":"Eckert GP, Wood WG, Muller WE (2001) Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranes. J Neural Transm 108(8\u20139):1051\u20131064","journal-title":"J Neural Transm"},{"key":"8663_CR54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"issue":"5","key":"8663_CR55","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0006-2952(02)01654-4","volume":"65","author":"C Kirsch","year":"2003","unstructured":"Kirsch C, Eckert GP, Muller WE (2003) Statins affect cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol 65(5):843\u2013856","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"8663_CR56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/13506120209114816","volume":"9","author":"C Kirsch","year":"2002","unstructured":"Kirsch C, Eckert GP, Mueller WE (2002) Cholesterol attenuates the membrane perturbing properties of beta-amyloid peptides. Amyloid 9(3):149\u2013159","journal-title":"Amyloid"},{"issue":"6","key":"8663_CR57","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0891-5849(94)00217-8","volume":"18","author":"M Choe","year":"1995","unstructured":"Choe M, Jackson C, Yu BP (1995) Lipid peroxidation contributes to age-related membrane rigidity. Free Radic Biol Med 18(6):977\u2013984","journal-title":"Free Radic Biol Med"},{"key":"8663_CR58","unstructured":"Lentz BR (1988) Membrane fluidity from anisotropy measurements. In: Loew LM (ed) Spectroscopic membrane probes, vol 1. CRC, Boca Raton, pp 13\u201342"},{"issue":"2","key":"8663_CR59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00005072-197404000-00008","volume":"33","author":"I Tellez-Nagel","year":"1974","unstructured":"Tellez-Nagel I, Johnson AB, Terry RD (1974) Studies on brain biopsies of patients with Huntington\u2019s chorea. J Neuropathol Exp Neurol 33(2):308\u2013332","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"8663_CR60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.28.1.23","volume":"28","author":"HH Goebel","year":"1978","unstructured":"Goebel HH, Heipertz R, Scholz W, Iqbal K, Tellez-Nagel I (1978) Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies. Neurology 28(1):23\u201331","journal-title":"Neurology"},{"issue":"5","key":"8663_CR61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","volume":"12","author":"S Gines","year":"2003","unstructured":"Gines S, Seong IS, Fossale E, Ivanova E, Trettel F, Gusella JF, Wheeler VC, Persichetti F, MacDonald ME (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington\u2019s disease knock-in mice. Hum Mol Genet 12(5):497\u2013508","journal-title":"Hum Mol Genet"},{"issue":"5","key":"8663_CR62","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/cne.21272","volume":"501","author":"E Petrasch-Parwez","year":"2007","unstructured":"Petrasch-Parwez E, Nguyen HP, Lobbecke-Schumacher M, Habbes HW, Wieczorek S, Riess O, Andres KH, Dermietzel R, Von Horsten S (2007) Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. J Comp Neurol 501(5):716\u2013730","journal-title":"J Comp Neurol"},{"issue":"3","key":"8663_CR63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10863-010-9290-y","volume":"42","author":"C Turner","year":"2010","unstructured":"Turner C, Schapira AH (2010) Mitochondrial matters of the brain: the role in Huntington\u2019s disease. J Bioenerg Biomembr 42(3):193\u2013198","journal-title":"J Bioenerg Biomembr"},{"issue":"10","key":"8663_CR64","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1194\/jlr.M026062","volume":"53","author":"L Ciarlo","year":"2012","unstructured":"Ciarlo L, Manganelli V, Matarrese P, Garofalo T, Tinari A, Gambardella L, Marconi M, Grasso M, Misasi R, Sorice M, Malorni W (2012) Raft-like microdomains play a key role in mitochondrial impairment in lymphoid cells from patients with Huntington\u2019s disease. J Lipid Res 53(10):2057\u20132068","journal-title":"J Lipid Res"},{"issue":"1","key":"8663_CR65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","volume":"16","author":"E Rockabrand","year":"2007","unstructured":"Rockabrand E, Slepko N, Pantalone A, Nukala VN, Kazantsev A, Marsh JL, Sullivan PG, Steffan JS, Sensi SL, Thompson LM (2007) The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet 16(1):61\u201377","journal-title":"Hum Mol Genet"},{"issue":"6","key":"8663_CR66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1019852720521","volume":"27","author":"MA LaFontaine","year":"2002","unstructured":"LaFontaine MA, Geddes JW, Butterfield DA (2002) 3-nitropropionic acid-induced changes in bilayer fluidity in synaptosomal membranes: implications for Huntington\u2019s disease 1. Neurochem Res 27(6):507\u2013511","journal-title":"Neurochem Res"},{"issue":"5","key":"8663_CR67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","volume":"59","author":"E Brouillet","year":"1999","unstructured":"Brouillet E, Conde F, Beal MF, Hantraye P (1999) Replicating Huntington\u2019s disease phenotype in experimental animals. Prog Neurobiol 59(5):427\u2013468","journal-title":"Prog Neurobiol"},{"issue":"2","key":"8663_CR68","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1471-4159.1984.tb00931.x","volume":"43","author":"F Schroeder","year":"1984","unstructured":"Schroeder F, Goetz IE, Roberts E (1984) Membrane anomalies in Huntington\u2019s disease fibroblasts. J Neurochem 43(2):526\u2013539","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"8663_CR69","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(02)03986-0","volume":"962","author":"GP Eckert","year":"2003","unstructured":"Eckert GP, Igbavboa U, Muller WE, Wood WG (2003) Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains. Brain Res 962(1\u20132):144\u2013150","journal-title":"Brain Res"},{"issue":"4","key":"8663_CR70","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbrc.2009.03.070","volume":"382","author":"GP Eckert","year":"2009","unstructured":"Eckert GP, Muller WE (2009) Presenilin 1 modifies lipid raft composition of neuronal membranes. Biochem Biophys Res Commun 382(4):673\u2013677","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"8663_CR71","first-page":"684","volume":"116","author":"WG Wood","year":"2011","unstructured":"Wood WG, Igbavboa U, Muller WE, Eckert GP (2011) Cholesterol asymmetry in synaptic plasma membranes. J Neurosci 116(5):684\u2013689","journal-title":"J Neurosci"},{"issue":"1","key":"8663_CR72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","volume":"4","author":"RC Block","year":"2010","unstructured":"Block RC, Dorsey ER, Beck CA, Brenna JT, Shoulson I (2010) Altered cholesterol and fatty acid metabolism in Huntington disease. J Clin Lipidol 4(1):17\u201323","journal-title":"J Clin Lipidol"},{"issue":"10","key":"8663_CR73","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","volume":"7","author":"JM Karasinska","year":"2011","unstructured":"Karasinska JM, Hayden MR (2011) Cholesterol metabolism in Huntington disease. Nat Rev Neurol 7(10):561\u2013572","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"8663_CR74","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","volume":"34","author":"M Valenza","year":"2011","unstructured":"Valenza M, Cattaneo E (2011) Emerging roles for cholesterol in Huntington\u2019s disease. Trends Neurosci 34(9):474\u2013486","journal-title":"Trends Neurosci"},{"issue":"3","key":"8663_CR75","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.biochi.2012.09.025","volume":"95","author":"V Leoni","year":"2013","unstructured":"Leoni V, Caccia C (2013) 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. Biochimie 95(3):595\u2013612","journal-title":"Biochimie"},{"issue":"32","key":"8663_CR76","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","volume":"30","author":"M Valenza","year":"2010","unstructured":"Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J, Pouladi MA, Fossale E, Nguyen HP, Riess O, MacDonald M, Wellington C, DiDonato S, Hayden M, Cattaneo E (2010) Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J Neurosci 30(32):10844\u201310850","journal-title":"J Neurosci"},{"key":"8663_CR77","doi-asserted-by":"crossref","unstructured":"Marullo M, Valenza M, Leoni V, Caccia C, Scarlatti C, De Mario A, Zuccato C, Di Donato S, Carafoli E, Cattaneo E (2012) Pitfalls in the detection of cholesterol in Huntington\u2019s disease models. PLoS Curr 4:e505886e9a1968","DOI":"10.1371\/505886e9a1968"},{"issue":"15","key":"8663_CR78","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","volume":"92","author":"E Brouillet","year":"1995","unstructured":"Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci U S A 92(15):7105\u20137109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8663_CR79","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","volume":"1802","author":"M Damiano","year":"2010","unstructured":"Damiano M, Galvan L, Deglon N, Brouillet E (2010) Mitochondria in Huntington\u2019s disease. Biochim Biophys Acta 1802(1):52\u201361","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"8663_CR80","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/14728221003730434","volume":"14","author":"VS Burchell","year":"2010","unstructured":"Burchell VS, Gandhi S, Deas E, Wood NW, Abramov AY, Plun-Favreau H (2010) Targeting mitochondrial dysfunction in neurodegenerative disease: part II. Expert Opin Ther Targets 14(5):497\u2013511","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"8663_CR81","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbadis.2009.10.007","volume":"1802","author":"PI Moreira","year":"2010","unstructured":"Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA (2010) Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 1802(1):212\u2013220","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"8663_CR82","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mito.2011.04.001","volume":"12","author":"V Shoshan-Barmatz","year":"2012","unstructured":"Shoshan-Barmatz V, Ben-Hail D (2012) VDAC, a multi-functional mitochondrial protein as a pharmacological target. Mitochondrion 12(1):24\u201334","journal-title":"Mitochondrion"},{"issue":"12","key":"8663_CR83","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Groyer G, Adams D, Schumacher M (2010) Translocator protein (18\u00a0kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9(12):971\u2013988","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"8663_CR84","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuropharm.2007.05.016","volume":"53","author":"AM Falchi","year":"2007","unstructured":"Falchi AM, Battetta B, Sanna F, Piludu M, Sogos V, Serra M, Melis M, Putzolu M, Diaz G (2007) Intracellular cholesterol changes induced by translocator protein (18\u00a0kDa) TSPO\/PBR ligands. Neuropharmacology 53(2):318\u2013329","journal-title":"Neuropharmacology"},{"issue":"4","key":"8663_CR85","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0006-2952(99)00151-3","volume":"58","author":"L Miccoli","year":"1999","unstructured":"Miccoli L, Oudard S, Beurdeley-Thomas A, Dutrillaux B, Poupon MF (1999) Effect of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide (PK11195), a specific ligand of the peripheral benzodiazepine receptor, on the lipid fluidity of mitochondria in human glioma cells. Biochem Pharmacol 58(4):715\u2013721","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"8663_CR86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1567-7249(03)00007-2","volume":"2","author":"AP Rolo","year":"2003","unstructured":"Rolo AP, Oliveira PJ, Moreno AJ, Palmeira CM (2003) Chenodeoxycholate induction of mitochondrial permeability transition pore is associated with increased membrane fluidity and cytochrome c release: protective role of carvedilol. Mitochondrion 2(4):305\u2013311","journal-title":"Mitochondrion"},{"issue":"3","key":"8663_CR87","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0006-291X(03)00627-2","volume":"304","author":"MP Mattson","year":"2003","unstructured":"Mattson MP, Liu D (2003) Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death. Biochem Biophys Res Commun 304(3):539\u2013549","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"8663_CR88","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","volume":"10","author":"NR Jana","year":"2001","unstructured":"Jana NR, Zemskov EA, Wang G, Nukina N (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum Mol Genet 10(10):1049\u20131059","journal-title":"Hum Mol Genet"},{"issue":"9","key":"8663_CR89","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M704704200","volume":"283","author":"D Lim","year":"2008","unstructured":"Lim D, Fedrizzi L, Tartari M, Zuccato C, Cattaneo E, Brini M, Carafoli E (2008) Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. J Biol Chem 283(9):5780\u20135789","journal-title":"J Biol Chem"},{"issue":"38","key":"8663_CR90","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1523\/JNEUROSCI.1867-08.2008","volume":"28","author":"X Wang","year":"2008","unstructured":"Wang X, Zhu S, Pei Z, Drozda M, Stavrovskaya IG, Del Signore SJ, Cormier K, Shimony EM, Wang H, Ferrante RJ, Kristal BS, Friedlander RM (2008) Inhibitors of cytochrome c release with therapeutic potential for Huntington\u2019s disease. J Neurosci 28(38):9473\u20139485","journal-title":"J Neurosci"},{"issue":"2","key":"8663_CR91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.22593","volume":"71","author":"K Magalon","year":"2012","unstructured":"Magalon K, Zimmer C, Cayre M, Khaldi J, Bourbon C, Robles I, Tardif G, Viola A, Pruss RM, Bordet T, Durbec P (2012) Olesoxime accelerates myelination and promotes repair in models of demyelination. Ann Neurol 71(2):213\u2013226","journal-title":"Ann Neurol"},{"issue":"2","key":"8663_CR92","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1142\/S0192415X07004813","volume":"35","author":"AL Rivard","year":"2007","unstructured":"Rivard AL, Steer CJ, Kren BT, Rodrigues CM, Castro RE, Bianco RW, Low WC (2007) Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat. Am J Chin Med 35(2):279\u2013295","journal-title":"Am J Chin Med"},{"issue":"6","key":"8663_CR93","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1046\/j.1471-4159.2000.0752368.x","volume":"75","author":"CM Rodrigues","year":"2000","unstructured":"Rodrigues CM, Stieers CL, Keene CD, Ma X, Kren BT, Low WC, Steer CJ (2000) Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. J Neurochem 75(6):2368\u20132379","journal-title":"J Neurochem"},{"issue":"2","key":"8663_CR94","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/exnr.2001.7755","volume":"171","author":"CD Keene","year":"2001","unstructured":"Keene CD, Rodrigues CM, Eich T, Linehan-Stieers C, Abt A, Kren BT, Steer CJ, Low WC (2001) A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington\u2019s disease. Exp Neurol 171(2):351\u2013360","journal-title":"Exp Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8663-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-8663-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8663-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T22:24:40Z","timestamp":1648592680000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-8663-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,18]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["8663"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-8663-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718313359.793495689","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,18]]}}}